Mutated EGFR-IN-1, CAS 1421372-66-8

Product Description: Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant and T790M resistance mutant.IC50 value:Target: Mutated EGFR inhibitorMore information can be found in Patent WO 2013014448 A1.2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer.

Applications: Cancer-Kinase/protease

Formula: C25H31N7O

References: [1]Patent WO 2013014448 A1. 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer .

CAS Number: 1421372-66-8

Molecular Weight: 445.56

Compound Purity: 99.89

Research Area: Cancer

Solubility: DMSO : ≥ 75 mg/mL

Target: EGFR

• Artikelnummer: MEXHY-78869-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-78869-10.1
• Verpackungseinheit: 10 mM/1 ml
• Mengeneinheit: STK